Statistics for A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors
Total visits
| views | |
|---|---|
| A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors | 0 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:9daa55e9-6d83-4e85-b4f7-1260100acc1c | 13 |
| Fountzilas2021Phase-AAM.pdf | 9 |
| java.util.UUID:5f834c96-70d7-439c-a2fc-b2e41077f86c | 6 |
| java.util.UUID:7a0d83d2-adce-48af-8e03-35a99b07dbca | 1 |